Quick Takeaways
- Trails Edge Capital Partners, LP filed SCHEDULE 13G for X4 Pharmaceuticals, Inc. Common Stock, par value $0.001 per share (XFOR).
- Disclosed ownership: 9.9%.
- Date of event: 11 Aug 2025.
Trails Edge Capital Partners, LP - 11 Aug 2025 SCHEDULE 13G Report for X4 Pharmaceuticals, Inc. Common Stock, par value $0.001 per share (XFOR)
- Filing Manager
- Trails Edge Capital Partners, LP
- Reporting Manager
- Trails Edge Capital Partners, LP
- Symbol
- XFOR
- Shares outstanding
- 23,405,586 shares
- Disclosed Ownership
- 2,317,153 shares
- Ownership
- 9.9%
- Form type
- SCHEDULE 13G
- Filing time
- 18 Aug 2025, 17:00:18 UTC
- Date of event
- 11 Aug 2025
- Next filing
- 17 Feb 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Trails Edge Capital Partners, LP disclosed 9.9% ownership in X4 Pharmaceuticals, Inc. Common Stock, par value $0.001 per share (XFOR) on 11 Aug 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 18 Aug 2025, 17:00.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Trails Edge Capital Partners, LP | 9.9% | 2,317,153 | 2,317,153 | 0 | By: Trails Edge Capital Partners, LLC, GP of Trails Edge Capital Partners, LP /s/ Ortav Yehudai | Ortav Yehudai / Chief Investment Officer of Trails Edge Capital Partners, LLC | |
| Trails Edge Biotechnology Master Fund, LP | 9.9% | 2,317,153 | 2,317,153 | 0 | By: Trails Edge GP, LLC, GP of Trails Edge Biotechnology Fund GP, LP, GP of Trails Edge Biotechnology Master Fund, LP /s/ Ortav Yehudai | Ortav Yehudai / Chief Investment Officer of Trails Edge GP, LLC | |
| Ortav Yehudai | 9.9% | 2,317,153 | 2,317,153 | 0 | /s/ Ortav Yehudai | Ortav Yehudai / Individual |